Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2011, Article ID 217378, 6 pages
http://dx.doi.org/10.1155/2011/217378
Clinical Study

Basal Cell Carcinomas in Gorlin Syndrome: A Review of 202 Patients

1Genetic Medicine, Manchester Academic Health Science Centre, University of Manchester and St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK
2University of Manchester, Oxford Road, Manchester M13 9PL, UK

Received 30 June 2010; Accepted 29 July 2010

Academic Editor: Arash Kimyai-Asadi

Copyright © 2011 Elizabeth A. Jones et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Lo Muzio, “Nevoid basal cell carcinoma syndrome (Gorlin syndrome),” Orphanet Journal of Rare Diseases, vol. 3, no. 1, article 32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. V. E. Kimonis, A. M. Goldstein, B. Pastakia et al., “Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome,” American Journal of Medical Genetics, vol. 69, no. 3, pp. 299–308, 1997. View at Google Scholar · View at Scopus
  3. D. G. R. Evans, E. J. Ladusans, S. Rimmer, L. D. Burnell, N. Thakker, and P. A. Farndon, “Complications of the naevoid basal cell carcinoma syndrome: results of a population based study,” Journal of Medical Genetics, vol. 30, no. 6, pp. 460–464, 1993. View at Google Scholar · View at Scopus
  4. D. G. R. Evans and P. A. Farndon, “Nevoid Basal Cell Carcinoma Syndrome. Gene Reviews at GeneTests: Medical Genetics Information Resource,” University of Washington, Seattle, Wash, USA. 1997–2006, 2010 http://www.geneclinics.org/.
  5. D. G. Evans, E. Howard, C. Giblin et al., “Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service,” American Journal of Medical Genetics A, vol. 152, pp. 327–332, 2010. View at Google Scholar
  6. R. Cowan, P. Hoban, A. Kelsey, J. M. Birch, R. Gattamaneni, and D. G. R. Evans, “The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma,” British Journal of Cancer, vol. 76, no. 2, pp. 141–145, 1997. View at Google Scholar · View at Scopus
  7. R. J. Gorlin, “Nevoid basal cell carcinoma (Gorlin) syndrome,” Genetics in Medicine, vol. 6, no. 6, pp. 530–539, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Shanley, J. Ratcliffe, A. Hockey et al., “Nevoid basal cell carcinoma syndrome: review of 118 affected individuals,” American Journal of Medical Genetics, vol. 50, no. 3, pp. 282–290, 1994. View at Google Scholar · View at Scopus
  9. D. G. R. Evans, L. A. Farndon, L. D. Burnell, H. Rao Gattamaneni, and J. M. Birch, “The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma,” British Journal of Cancer, vol. 64, no. 5, pp. 959–961, 1991. View at Google Scholar · View at Scopus
  10. H. Hahn, C. Wicking, P. G. Zaphiropoulos et al., “Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome,” Cell, vol. 85, no. 6, pp. 841–851, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. R. L. Johnson, A. L. Rothman, J. Xie et al., “Human homolog of patched, a candidate gene for the basal cell nevus syndrome,” Science, vol. 272, no. 5268, pp. 1668–1671, 1996. View at Google Scholar · View at Scopus
  12. M. R. Gailani, M. Stahle-Backdahl, D. J. Leffell et al., “The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas,” Nature Genetics, vol. 14, no. 1, pp. 78–81, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Lindström, T. Shimokawa, R. Toftgård, and P. G. Zaphiropoulos, “PTCH mutations: distribution and analyses,” Human Mutation, vol. 27, no. 3, pp. 215–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. E. Bale and K.-P. Yu, “The hedgehog pathway and basal cell carcinomas,” Human Molecular Genetics, vol. 10, no. 7, pp. 757–762, 2001. View at Google Scholar · View at Scopus
  15. C. Wicking, S. Shanley, I. Smyth et al., “Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the patched protein, and no genotype- phenotype correlations are evident,” American Journal of Human Genetics, vol. 60, no. 1, pp. 21–26, 1997. View at Google Scholar · View at Scopus
  16. A. Chidambaram, A. M. Goldstein, M. R. Gailani et al., “Mutations in the human homologue of the Drosophila patched gene in Caucasian and African-American nevoid basal cell carcinoma syndrome patients,” Cancer Research, vol. 56, no. 20, pp. 4599–4601, 1996. View at Google Scholar · View at Scopus
  17. N. Boutet, Y.-J. Bignon, V. Drouin-Garraud et al., “Spectrum of PTCH1 mutations in French patients with Gorlin syndrome,” Journal of Investigative Dermatology, vol. 121, no. 3, pp. 478–481, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Soufir, B. Gerard, M. Portela et al., “PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study,” British Journal of Cancer, vol. 95, no. 4, pp. 548–553, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. D. G. R. Evans, L. Trueman, A. Wallace, S. Collins, and T. Strachan, “Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations,” Journal of Medical Genetics, vol. 35, no. 6, pp. 450–455, 1998. View at Google Scholar · View at Scopus
  20. M. E. Baser, J. M. Friedman, D. Aeschliman et al., “Predictors of the risk of mortality in neurofibromatosis 2,” American Journal of Human Genetics, vol. 71, no. 4, pp. 715–723, 2002. View at Google Scholar · View at Scopus
  21. D. R. Davies, J. G. Armstrong, N. Thakker et al., “Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene,” American Journal of Human Genetics, vol. 57, no. 5, pp. 1151–1158, 1995. View at Google Scholar · View at Scopus
  22. A. Zibat, A. Uhmann, F. Nitzki et al., “Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts,” Carcinogenesis, vol. 30, no. 6, pp. 918–926, 2009. View at Publisher · View at Google Scholar · View at Scopus